XNA Aptamer Particle Display Technology

Tech ID: 34032 / UC Case 2019-668-0

Brief Description

An innovative mid-throughput technique for screening and optimizing threose nucleic acid (TNA) aptamers for protein-binding activity.

Full Description

This technology introduces a novel method for rapidly screening threose nucleic acids (TNA) aptamers for affinity and specificity to a protein target of interest. It leverages bead-based DNA particle display, facilitating the high-throughput selection of aptamers with unique properties such as increased stability and chemical functionality. This advancement extends the application of DNA particle display to XNA-based aptamers, overcoming the previous limitation of DNA polymerase's incompatibility with artificial genetic nucleotides.

Suggested uses

  • Drug discovery and development, specifically in the area of therapeutic aptamers 
  • Diagnostic tools for detecting specific biomarkers with high affinity and specificity. 
  • Research and development in synthetic biology, particularly in the study and application of synthetic genetic materials.

Advantages

  • Facilitates mid-throughput screening of unnatural aptamers with desired properties. 
  • Compatible with standard fluorescence-activated flow cytometry instruments. 
  • Avoids tedious synthesis and purification approaches required for individual aptamer sequences

Patent Status

Country Type Number Dated Case
United States Of America Published Application 2020-034738 11/05/2020 2019-668
 

Additional Patent Pending

Related Materials

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Other Information

Keywords

particle display, aptamers, XNA, TNA, screening assay

Categorized As


5270 California Avenue / Irvine,CA
92697-7700 / Tel: 949.824.2683
  • Facebook
  • Twitter
  • Twitter
  • Twitter
  • Twitter